A fever in India is often dismissed with a familiar refrain, “just viral.” But a new analysis by diagnostics firm Thyrocare suggests that this casual approach may be masking a far more serious public health concern.
Drawing on data from over 1.08 lakh patients who underwent comprehensive fever testing between 2023 and 2025, the study finds that nearly one in three individuals tested positive for significant infections such as typhoid, dengue, malaria, chikungunya, or leptospirosis. The findings underscore a critical gap between perception and reality when it comes to fever management in the country.
Typhoid emerged as the most commonly detected infection, found in 18.1 per cent of those tested, followed by dengue at 14.4 per cent. While malaria, chikungunya and leptospirosis accounted for a smaller share, their presence adds to what experts describe as a substantial infectious disease burden hiding behind seemingly routine symptoms.
For your daily dose of medical news and updates, visit: HEALTH
The data also reveals that fever is often not a standalone condition but part of a more complex clinical picture. Nearly 10 per cent of patients who tested positive for infections had co-infections, most commonly a combination of dengue and typhoid, posing additional challenges for diagnosis and treatment.
“Fever is not a diagnosis; it is a signal,” said Rahul Guha, managing director and CEO of Thyrocare, emphasising the need to move from reactive treatment to timely and informed intervention.
More than just a temperature spike
The study also points to significant physiological stress associated with fever. Laboratory markers indicate that many patients experience systemic effects, including low platelet counts and liver dysfunction.
Thrombocytopenia, or low platelet levels, was observed in 27 per cent of fever patients, almost double the rate seen in non-fever cases. The condition was particularly pronounced among malaria patients, with nearly 80 per cent showing a platelet drop. Dengue patients also showed notable declines.
Similarly, elevated liver enzymes, an indicator of liver stress, were widespread. More than half of the fever patients had raised SGOT levels, while 37 per cent showed elevated SGPT levels, both significantly higher than in individuals without fever.
“These markers highlight that fever is often a systemic event, not just a transient rise in body temperature,” said Dr Preet Kaur, Chief Scientific Officer at Thyrocare.
The analysis also tracked how infection patterns evolved over the three-year period. Dengue cases showed a decline, while malaria, though relatively low in absolute numbers, registered a gradual increase. Typhoid and chikungunya saw a spike in 2024 before easing in 2025.
Seasonal trends remained consistent with known epidemiological patterns. Dengue cases typically peaked around October, while malaria showed higher transmission during monsoon months between May and September.
Geographical differences were also evident, with certain regions consistently reporting higher positivity rates. However, the overall decline in dengue and typhoid in many areas may indicate improved control measures or changing transmission dynamics.
The study found subtle but notable gender differences. Overall infection positivity was slightly higher among women (32 per cent compared to 29 per cent in men), driven largely by higher typhoid detection. In contrast, malaria was more than twice as common in men.
Separate analysis of standalone tests, covering 2.59 lakh patients, also showed a significant disease burden, with an overall positivity rate of 22.6 per cent. While dengue accounted for the highest number of tests, chikungunya recorded one of the highest positivity rates at 23 per cent, despite fewer people being tested.
Experts note that while standalone testing helps identify specific infections, it may miss co-existing illnesses, reinforcing the case for comprehensive diagnostic panels.
The findings arrive at a time when India continues to grapple with seasonal outbreaks and evolving infectious disease patterns. Public health experts have long warned against self-medication and delayed diagnosis, both of which can worsen outcomes, particularly in diseases like dengue or leptospirosis, where early intervention is crucial.
The Thyrocare study adds data-driven weight to those concerns. It challenges a deeply ingrained cultural tendency to downplay fever and instead calls for a more cautious, evidence-based approach.
For clinicians, it reinforces the importance of timely testing. For patients, it serves as a reminder that what seems like a routine fever could signal something far more serious.